SITC's Cancer Immunotherapy Guidelines program is a collection of clinical practice guidelines (CPGs) developed by multi-disciplinary panels of experts who draw from their own practical experience as well as evidence in the published literature and clinical trial data to develop evidence- and consensus-based recommendations. SITC uses as a model the Institute of Medicine's 2011 "Standards for Developing Trustworthy Clinical Practice Guidelines" to ensure recommendations are unbiased, transparent, and balanced.
The recommendations in this guideline provide a valuable clinical decision-making tool to help guide oncologists and other advanced practice providers with selection of appropriate immunotherapeutic regimens, diagnostics and biomarker testing, and patient quality of life considerations.
"Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of melanoma, version 3.0" published in Journal for ImmunoTherapy of Cancer (JITC) on October 18, 2023.
SITC continuously evaluates the field for practice-changing data and new FDA approvals. The SITC Melanoma Expert Panel will guide the development of updates within this CPG. Updates will appear in the SITC CPG Mobile App and as annotated text accompanying the original publication in JITC.
Download the app for quick access to the melanoma CPG with interactive tools and companion education resources.
SITC is pleased to offer companion education resources in support of the gastrointestinal cancer CPG. These activities feature faculty comprised of the guideline expert panel and are designed to provide a deeper understanding of the recommendations in the SITC guidelines and how to apply them in various clinical scenarios. The education available features one-hour webinars, available free and on-demand, that take a deeper look at the guideline recommendations.
Practical Management Pearls for Immunotherapy for the Treatment of Melanoma
Case Studies in Immunotherapy for the Treatment of Melanoma
Tel: +1 414 271 2456 | Fax: +1 414 276 3349 | Email: email@example.com